Approved leukemia drug monitored in real patients
NCT ID NCT04826523
Summary
This study monitored the safety and effectiveness of the approved leukemia drug venetoclax in real-world patients with acute myeloid leukemia (AML) in South Korea. About 150 adult patients who were prescribed the drug for the first time were observed for about 7 months during their regular treatment. Researchers tracked side effects and how well the drug worked to control the cancer in a routine medical setting.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA (AML) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chonnam National University Hwasun Hospital /ID# 257478
Hwasun-gun, Jeonranamdo, 58128, South Korea
-
Gachon University Gil Medical Center /ID# 239008
Incheon, Gyeonggido, 21565, South Korea
-
Korea University Anam Hospital /ID# 231022
Seoul, Seoul Teugbyeolsi, 02841, South Korea
-
Kosin University Gospel Hospital /ID# 257399
Busan, Busan Gwang Yeogsi, 49267, South Korea
-
Kyungpook National University Hospital /ID# 257398
Daegu, Daegu Gwang Yeogsi, 41944, South Korea
-
Pusan National University Hospital /ID# 239010
Busan, Busan Gwang Yeogsi, 49241, South Korea
-
Samsung Medical Center /ID# 239009
Seoul, Seoul Teugbyeolsi, 06351, South Korea
-
Seoul National University Hospital /ID# 257477
Seoul, Seoul Teugbyeolsi, 03080, South Korea
-
Yeungnam University Medical Center /ID# 239007
Daegu, 42415, South Korea
-
Yonsei University Health System Severance Hospital /ID# 239006
Seoul, 03722, South Korea
Conditions
Explore the condition pages connected to this study.